These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 509787)

  • 1. Reduction of dialyzer fibrin deposition with sulphinpyrazone.
    Woods HF; Ash G; Parsons V; Weston MJ
    Clin Nephrol; 1979 Sep; 12(3):122-6. PubMed ID: 509787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrin deposition in disposable dialyzers before and after re-use.
    Gunnarsson B; Asaba H; Kiibus A; Söderborg B; Wiklund S; Bergström J
    Clin Nephrol; 1979 Sep; 12(3):117-21. PubMed ID: 509786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions.
    Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ
    J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone.
    Ludlam CA; Allan N; Blandford RB; Dowdle R; Bentley NJ; Bloom AL
    Thromb Haemost; 1981 Dec; 46(4):743-6. PubMed ID: 6460338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodialysis without anticoagulant: haemostasis parameters, fibrinogen kinetic, and dialysis efficiency.
    Româo JE; Fadil MA; Sabbaga E; Marcondes M
    Nephrol Dial Transplant; 1997 Jan; 12(1):106-10. PubMed ID: 9027783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does an alteration of dialyzer design and geometry affect biocompatibility parameters?
    Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J
    Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcus-induced thrombocytopenia in rabbits.
    Goldblum SE; Simon TL; Thilsted JP; Babcock TL
    J Lab Clin Med; 1985 Sep; 106(3):298-307. PubMed ID: 4031631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcoronary platelet thromboxane A2 formation without platelet trapping in patients with coronary stenosis-effect of sulphinpyrazone treatment.
    Cortellaro M; Boschetti C; Antoniazzi V; Moreo G; Repetto S; Verna E; Boscarini M; Limido A; Binaghi G; Polli EE
    Thromb Haemost; 1983 Dec; 50(4):857-9. PubMed ID: 6665767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysbaric osteonecrosis: a consequence of intravascular bubble formation, endothelial damage, and platelet thrombosis.
    Slichter SJ; Stegall P; Smith K; Huang TW; Harker LA
    J Lab Clin Med; 1981 Oct; 98(4):568-90. PubMed ID: 7288270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
    Gunnarsson B; Asaba H; Dawidson S; Wilhelmsson S; Bergström J
    Clin Nephrol; 1981 Mar; 15(3):135-42. PubMed ID: 7273488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A higher blood flow window of reduced thrombogenicity and acceptable fragmentation in a hollow fiber hemodialyzer.
    Dewanjee MK; Kapadvanjwala M; Mao WW; Jy W; Ahn Y; Ruzius K; Ghafouripour AK; Serafini AN; Sfakianakis GN
    ASAIO J; 1993; 39(3):M363-7. PubMed ID: 8268560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment.
    Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrinogen and fibrin structure in patients with cirrhosis of the liver (author's transl)].
    Klingemann HG; Brunswig D; Liehr H
    Z Gastroenterol; 1978 Sep; 16(9):564-73. PubMed ID: 706517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.